Nuo Therapeutics Company

Nuo Therapeutics is a biotechnology company that develops, sells, and licenses regenerative biological therapies to primarily address the areas of wound care, inflammation, and angiogenesis. The Company markets the AutoloGel System, a device for the production of platelet rich plasma gel derived from the patient's own blood. The AutoloGel System is cleared by the United States Food and Drug Administration for use on a variety of exuding wounds. Nuo Therapeutics is headquartered in Gaithersburg, Maryland.
Technology: Others
Industry: Biotechnology, Health Care, Manufacturing, Medical, Pharmaceutical, Therapeutics, Wellness
Headquarters: Gaithersburg, Maryland, United States
Founded Date: 1987-01-01
Employees Number: 11-50
Funding Status: IPO
Acquisitions Number: 1
Investors Number: 3
Total Funding: $112.8M
Estimated Revenue: Less than $1M
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership